Position in DCTH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$69,206
+$24,477 QoQ
Shares Held
5,497
+14.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 119 holders
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in DCTH Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026FMR LLC holds $9,354,933,608 across 97 Medical Devices names. DCTH ranks #68 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
45,702,845 | $1,950,597,421 | |
| 2 | BRKR |
Bruker Corp
|
20,683,975 | $1,417,902,444 | |
| 3 | ABT |
Abbott Laboratories
|
13,423,080 | $1,218,010,276 | |
| 4 | EW |
Edwards Lifesciences Corp
|
8,435,949 | $763,115,943 | |
| 5 | TXG |
10x Genomics, Inc.
|
17,629,266 | $675,906,056 | |
| 6 | SYK |
Stryker Corp
|
1,702,373 | $535,975,113 | |
| 7 | TMDX |
TransMedics Group, Inc.
|
5,133,328 | $340,955,642 | |
| 8 | NVCR |
NovoCure Ltd
|
17,373,078 | $263,202,131 |
All Filings in DCTH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,206 | 5,497 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $44,729 | 4,820 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $75,568 | 7,482 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,815 | 262 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,405 | 471 | Shares | Defined | 2025-08-14 | |
| 2023-12-31 | $24,510 | 5,892 | Shares | Defined | 2024-02-13 | |
| 2020-12-31 | $17 | 1 | Shares | Defined | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||